DHS - ETF AI Analysis

Compare

Top Page

WisdomTree U.S. High Dividend Fund (DHS)

Rating:70Outperform

Price Target:

$108.00

The ETF DHS, managed by WisdomTree, has a solid overall rating, reflecting its focus on high-dividend U.S. stocks. Strong holdings like Johnson & Johnson and PepsiCo contribute positively to the fund’s performance due to their robust financial results, strategic growth initiatives, and optimistic earnings outlooks. However, weaker holdings such as Philip Morris and AbbVie, which face valuation concerns and financial stability risks, may slightly weigh on the fund’s rating. A key risk factor is the ETF's concentration in a few sectors, which could limit diversification and expose it to sector-specific challenges.

Positive Factors

Strong Top Holdings

Several of the largest positions, like Johnson & Johnson and AbbVie, have delivered strong year-to-date performance, supporting the fund’s returns.

Sector Diversification

The ETF is spread across multiple sectors, including Health Care, Financials, and Consumer Defensive, reducing reliance on any single industry.

Reasonable Expense Ratio

The fund’s expense ratio is relatively low, making it cost-effective compared to many actively managed funds.

Negative Factors

Over-Concentration in U.S. Market

The ETF is almost entirely focused on U.S. companies, limiting exposure to international markets and diversification.

Energy Sector Sensitivity

Significant exposure to the Energy sector could make the fund vulnerable to oil price fluctuations and sector-specific risks.

Mixed Performance Among Holdings

While some holdings have performed well, others like AT&T and PepsiCo have shown weaker year-to-date growth, potentially dragging on overall returns.

DHS vs. SPDR S&P 500 ETF (SPY)

AUM1.28B

RegionNorth America

Expense Ratio0.38%

Beta0.46

IssuerWisdomTree

Inception DateJun 16, 2006

Dividend Yield3.38%

Asset ClassEquity

Index TrackedWisdomTree U.S. High Dividend Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume21,546

30 Day Avg. Volume25,583

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

112.53

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering366

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

DHS Summary

The WisdomTree U.S. High Dividend Fund (DHS) is an ETF that focuses on U.S. companies known for paying high dividends. It follows the WisdomTree U.S. High Dividend Index and includes well-known companies like Johnson & Johnson and AbbVie. This fund is ideal for investors looking to earn steady income from dividends while gaining exposure to a mix of sectors such as healthcare, financials, and consumer defensive. However, since it heavily relies on dividend-paying stocks, its performance can be affected by market conditions or changes in dividend policies.

How much will it cost me?The WisdomTree U.S. High Dividend Fund (DHS) has an expense ratio of 0.38%, meaning you’ll pay $3.80 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to focus on high dividend-paying stocks, which requires more research and management. It’s designed for investors seeking income and stability through dividends.

What would affect this ETF?The WisdomTree U.S. High Dividend Fund (DHS) could benefit from stable or rising interest in dividend-paying stocks, especially during periods of economic uncertainty when investors seek reliable income sources. However, it may face challenges if interest rates rise significantly, as higher yields on bonds could make dividend-focused investments less attractive. Additionally, its heavy exposure to sectors like Health Care and Energy means it could be impacted by regulatory changes or fluctuations in commodity prices.

DHS Top 10 Holdings

The WisdomTree U.S. High Dividend Fund (DHS) leans heavily on health care, financials, and consumer defensive sectors, with names like Johnson & Johnson and AbbVie providing steady support thanks to robust earnings and growth prospects. Energy giants Exxon Mobil and Chevron have shown mixed performance, with strategic initiatives offsetting short-term market challenges. Meanwhile, Philip Morris and AT&T are holding the fund back, as high leverage and bearish technical indicators weigh on their momentum. With its U.S.-focused portfolio, DHS offers a stable income stream but remains sensitive to sector-specific headwinds.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
JNJ	Johnson & Johnson	6.59%	$84.41M	$480.85B	30.72%	78 Outperform
ABBV	AbbVie	5.52%	$70.65M	$413.57B	40.40%	62 Neutral
PM	Philip Morris	5.38%	$68.94M	$237.79B	20.31%	62 Neutral
XOM	Exxon Mobil	5.16%	$66.15M	$496.28B	0.34%	75 Outperform
MO	Altria Group	3.93%	$50.32M	$97.58B	5.51%	64 Neutral
CVX	Chevron	3.92%	$50.24M	$311.73B	-3.75%	74 Outperform
PEP	PepsiCo	3.73%	$47.78M	$202.13B	-5.07%	78 Outperform
T	AT&T	3.16%	$40.48M	$180.57B	12.63%	72 Outperform
GILD	Gilead Sciences	2.98%	$38.11M	$153.96B	44.93%	77 Outperform
MRK	Merck & Company	2.85%	$36.52M	$230.48B	-0.11%	78 Outperform

DHS Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

99.83

Positive

100DMA

98.90

Positive

200DMA

96.19

Positive

Market Momentum

MACD

0.17

Negative

RSI

55.30

Neutral

STOCH

67.73

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DHS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 99.53, equal to the 50-day MA of 99.83, and equal to the 200-day MA of 96.19, indicating a bullish trend. The MACD of 0.17 indicates Negative momentum. The RSI at 55.30 is Neutral, neither overbought nor oversold. The STOCH value of 67.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DHS.

DHS Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
DHS	―	―	$1.28B	0.38%	70 Outperform
SCHD	―	―	$70.18B	0.06%	72 Outperform
FVD	―	―	$8.58B	0.61%	70 Outperform
SPYD	―	―	$7.22B	0.07%	67 Neutral
FDL	―	―	$5.96B	0.43%	72 Outperform
PEY	―	―	$1.03B	0.54%	67 Neutral

Performance Comparison

DHS

WisdomTree U.S. High Dividend Fund

100.40

4.39

4.57%

SCHD

Schwab US Dividend Equity ETF

―

FVD

First Trust Value Line Dividend Index Fund

―

SPYD

SPDR Portfolio S&P 500 High Dividend ETF

―

FDL

First Trust Morningstar Dividend Leaders Index Fund

―

PEY

Invesco High Yield Equity Dividend Achievers ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents